A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis

BACKGROUND: Interleukin 12 (IL-12), a cytokine that promotes generation of helper T cells subtype 1, is increased in multiple sclerosis. Albuterol sulfate, a β2-adrenergic agonist, reduces IL-12 expression, so we tested the effect of albuterol as an add-on treatment to glatiramer acetate therapy. OB...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Khoury, Samia J., Healy, Brian C., Kivisäkk, Pia, Viglietta, Vissia, Egorova, Svetlana, Guttmann, Charles R. G., Wedgwood, Josiah F., Hafler, David A., Weiner, Howard L., Buckle, Guy, Cook, Sandra, Reddy, Susheel
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954052/
https://ncbi.nlm.nih.gov/pubmed/20837847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2010.222
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars